Standard of Care Treatment

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisNCT06193889Kyverna TherapeuticsPhase 2, Phase 3Recruiting2027-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.